Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 48
- Registration Number
- NCT00268489
- Locations
- 🇺🇸
Billings Clinic Cancer Center, Billings, Montana, United States
🇺🇸Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States
🇺🇸Community Medical Center, Missoula, Montana, United States
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 2334
- Registration Number
- NCT00265850
- Locations
- 🇺🇸
Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
🇺🇸Northside Hospital Cancer Center, Atlanta, Georgia, United States
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2020-02-12
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 622
- Registration Number
- NCT00265759
- Locations
- 🇺🇸
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States
🇺🇸Doctor's Hospital of Laredo, Laredo, Texas, United States
🇺🇸M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 48
- Registration Number
- NCT00265733
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
- First Posted Date
- 2005-10-13
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 97
- Registration Number
- NCT00238238
- Locations
- 🇺🇸
Menorah Medical Center, Overland Park, Kansas, United States
🇺🇸Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
🇺🇸Memorial Hospital, Carthage, Illinois, United States
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 50
- Registration Number
- NCT00227565
- Locations
- 🇺🇸
Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States
🇺🇸St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States
🇺🇸Rush-Copley Cancer Care Center, Aurora, Illinois, United States
American Ginseng in Treating Patients With Cancer-Related Fatigue
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 290
- Registration Number
- NCT00182780
Octreotide in Treating Patients With Cancer-Related Malignant Ascites
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 33
- Registration Number
- NCT00182754
- Locations
- 🇺🇸
Swedish Medical Center, Englewood, Colorado, United States
🇺🇸Bismarck Cancer Center, Bismarck, North Dakota, United States
🇺🇸Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 58
- Registration Number
- NCT00124618
- Locations
- 🇺🇸
Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, United States
🇺🇸CCOP - Montana Cancer Consortium, Billings, Montana, United States
🇺🇸Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States
Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
- Conditions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 62
- Registration Number
- NCT00117975
- Locations
- 🇺🇸
McDonough District Hospital, Macomb, Illinois, United States
🇺🇸Eureka Community Hospital, Eureka, Illinois, United States
🇺🇸CancerCare of Maine at Eastern Maine Medial Center, Bangor, Maine, United States